Cardiovascular Medicine is one of the most widely read medical journals in Switzerland. In particular, cardiologists, angiologists and general practitioners appreciate the articles on a wide variety of topics in cardiovascular medicine.
With the first issue in 2023, there are several innovations. A new layout will modernise the journal and lead to uniformity within EMH. In addition, the value of the printed product will be increased. There is a new simplified “manuscript manager” to streamline article submission and editing. The editorial board will also be expanded, and in particular various young clinical cardiologists and cardiovascular scientists will be involved. We will report on this in one of the next issues.
The Swiss Society of Cardiac Surgery (SGHC SSCC) has also decided that Cardiovascular Medicine will become the official national journal of the society. This is a logical consequence, since nowadays in many cardiovascular diseases the “heart team”, primarily consisting of cardiologists and cardiac surgeons, decides on the optimal management and procedure for patients. In this sense, the journal Cardiovascular Medicine should involve cardiac surgeons and reflect the clinical, interdisciplinary daily routine in the medical journal.
Peter Matt
The SGHC SSCC is pleased to have received a warm welcome from the editors of the journal and EMH. We are convinced that the future collaboration will be successful. There will be a new “Cardiac Surgery” Editor-in-Chief of the journal, Prof. Peter Matt, currently President of the SGHC SSCC and Director of Cardiac Surgery at the Luzerner Kantonsspital. Dr Luca Koechlin, cardiac surgeon at the University Hospital Basel, will serve as Deputy Editor.
Together with other cardiac surgeons on the Editorial Board, we look forward to new educational articles, reviews, editorials from a cardiac surgery perspective, case reports, original articles, new formats, and the joint further development and design of the journal.
In addition to all these formal innovations, I would like to point out the interesting content of this issue.
Prof. Lüscher writes about evaluation and ranking of researchers and universities. Is research, teaching and the performance of a university generally measurable at all? If so, how? In an article on post-traumatic stress in cardiology, it is shown that in 4–16% of patients after acute coronary syndrome post-traumatic stress disorder exists in the longer term. This is different from other, external traumas – management and therapy is correspondingly different. A “Case Report” reports on interventional access via the superior vena cava for pulmonary vein isolation in symptomatic atrial fibrillation. An original article on transvenous lead extraction shows that a structured lead extraction programme leads to very good results with low complication rates and a broadening of the indication. Furthermore, there is an overview of the most important results of different cardiovascular studies on SGLT2 inhibitors. In addition, there is an “Image” on the rare event of isolated pulmonary valve endocarditis.
Personally, I look forward to the many exciting articles in Cardiovascular Medicine in 2023, and I am convinced that the various innovations will contribute to the continued success of the journal.
I would be pleased if some of the published articles could support or even optimise your daily work in the treatment of patients with cardiovascular diseases.
